Orion Corporation: Transfer of 47,279 own B shares on 1 March 2019

NASDAQ Market News March 1, 2019

NASDAQ Market News
Click here to email author

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Breakthrough Results from Phase 2 Clinical Trial of Bermekimab in the Treatment of Atopic Dermatitis (AD) to be Presented on March 2, 2019 at American Academy of Dermatology Annual Meeting

Ads